Navigation Links
Frost & Sullivan's Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells
Date:3/4/2009

MOUNTAIN VIEW, Calif., March 4 /PRNewswire/ -- The Healthcare practice at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the North American biopharmaceuticals market to be held on Thursday, March 5, 2009 at 10:00 a.m. PST.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

The biopharmaceutical industry has witnessed healthy growth and is experiencing several notable trends, such as the increased use of contract manufacturing organizations and the targeting of biotechnology companies for mergers and acquisitions by pharmaceutical companies or other biotechnology companies. In addition, this industry faces issues that are immersed in heated debate, such as the approval pathway of biosimilars.

This briefing will benefit strategic planners, business development managers, research professionals, marketing managers, and those who are considering entering this dynamic market. Highlights of the briefing include an analysis of overall market trends, general market sizing, and a look at selected issues.

"One of the hot topics in the biopharmaceutical market is the ethical debate surrounding the research and use of embryonic stem cells," notes Frost & Sullivan Research Analyst Katheryn Symank. "This issue is immersed in both political and ethical controversy. Some argue that the use of human embryonic stem cells is unethical while others support their use because of the potential medical good to the population."

To participate, please email Stephanie Ochoa, Corporate Communications, at stephanie.ochoa@frost.com with the following information: your full name, title, company name, company te
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Perceptive Informatics Receives Frost & Sullivan Product Line Strategy Award
2. Pioneer(R) Surgical Technology, Inc. Wins Frost & Sullivans 2009 North American Orthopaedic Tissue Engineering Technology Innovation Award
3. Frost & Sullivan Names Naviscan a Leader in the Future of Molecular Breast Imaging
4. Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
5. Frost & Sullivan Sees Microdosing as Compelling Advantage for Big Pharma
6. Frost & Sullivan Recognizes ESBATechs Innovation in Developing Antibody Fragments for Biologic Therapeutics
7. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
8. Frost & Sullivan Commends Honeywell Enraf for Cutting-Edge Products and Post-Sales Support
9. Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award
10. Frost & Sullivan Awards Baxters BioPharma Solutions Business the 2008 North American Customer Service Leadership of the Year Award
11. Frost & Sullivan Presents CorMatrix Cardiovascular Inc. with 2008 Healthcare Innovation Award for the Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015 Synthetic ... pathogen-specific therapies for serious infections and diseases, with ... that clinical data supporting the development of SYN-004, ... beta-lactam intravenous (IV) antibiotics within the gastrointestinal (GI) ... gut microbiome for the prevention of C. ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Holomic is ... can read both chromatographic and fluorescent rapid tests with ... of high performance, quantitative readers and is already selling ... HRDR-400 is a first of its kind offering for ... instrument. , Dr. Neven Karlovac, CEO of Holomic ...
(Date:4/1/2015)... 2015  Spherix Incorporated (Nasdaq: SPEX ) -- an ... and monetization of intellectual property, today announced that ... service global investment bank specializing in micro, small, ... featuring Spherix. The report, authored by ... at Chardan, was published on March 31, 2015. ...
(Date:4/1/2015)... NEW YORK CITY and ... leading provider of market research reports and solutions, MarketResearch.com is ... that 2015 will be a year of market growth and ... operating a stem cell company or cord blood bank, competing ... must analyze market conditions, predict industry trends, and act on ...
Breaking Biology Technology:Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 3Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 4Holomic to Introduce the First Dual, Chromatographic and Fluorescent Rapid Test Reader, the HRDR-400 2Chardan Capital Issues Industry Note Covering Spherix 2Chardan Capital Issues Industry Note Covering Spherix 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4
... has found that a currently available yet underused vaccine against ... unvaccinated neighbors of vaccinees. The study, conducted by ... Institute of Cholera and Enteric Diseases (NICED) in Kolkata, India, ... New England Journal of Medicine (NEJM). The IVI, based ...
... , LYNBROOK, N.Y., July 22 BioSpecifics Technologies ... in class collagenase-based products, today announced that BioSpecifics, President, Tom Wegman, ... Conference on Wednesday, July 29, 2009, at 9:30am CT at the ... A live webcast of the presentation can be accessed under ...
... July 22 Sirnaomics, Inc. (www.sirnaomics.com) announced today ... business innovation research) grant from National Cancer Institute ... novel siRNA therapeutics to treat lung cancer. Sirnaomics, ... is dedicated to advancing RNA interference (RNAi) Technology ...
Cached Biology Technology:Vi typhoid vaccine proves highly effective in young children 2Vi typhoid vaccine proves highly effective in young children 3Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics 2Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics 3
(Date:3/31/2015)... 2015  Elephant Talk Communications Corp. (NYSE MKT: ETAK) ... Software Defined Network Architecture (ET Software DNA® 2.0) platforms ... approximately $20.4 million for the year ended December 31, ... the year ended December 31, 2013. ... completed its multi-year transition away from its legacy landline ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... the "Global Gesture Recognition Market in Automotive Sector ... analysts forecast the Global Gesture Recognition market in Automotive ... the period 2013-2018. Gesture recognition is the ... different gestures of an individual. Gesture recognition technology can ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... grow replacement bones with stem cell technology, thanks to research ... Many scientists are currently trying to create bone-like materials, ... damaged or fractured bones, or who have had parts of ... materials could be inserted into cavities so that real bone ...
... WASHINGTON, DC U.S. Secretary of Energy Steven ... 46 of the 100 awards given out this year ... with promising commercial potential. The coveted awards are ... materials or software developed throughout the world and introduced ...
... bad-tasting and potentially poisonous foods may also play a role ... study by scientists at the University of Iowa Roy J. ... help explain why injured lungs are susceptible to further damage. ... Express, shows that receptors for bitter compounds that are ...
Cached Biology News:Scientists closer to making implantable bone material, thanks to new research 2DOE-funded research projects win 46 R&D 100 Awards for 2009 2DOE-funded research projects win 46 R&D 100 Awards for 2009 3DOE-funded research projects win 46 R&D 100 Awards for 2009 4DOE-funded research projects win 46 R&D 100 Awards for 2009 5DOE-funded research projects win 46 R&D 100 Awards for 2009 6DOE-funded research projects win 46 R&D 100 Awards for 2009 7DOE-funded research projects win 46 R&D 100 Awards for 2009 8DOE-funded research projects win 46 R&D 100 Awards for 2009 9DOE-funded research projects win 46 R&D 100 Awards for 2009 10DOE-funded research projects win 46 R&D 100 Awards for 2009 11DOE-funded research projects win 46 R&D 100 Awards for 2009 12DOE-funded research projects win 46 R&D 100 Awards for 2009 13DOE-funded research projects win 46 R&D 100 Awards for 2009 14Airway cells use 'tasting' mechanism to detect and clear harmful substances 2
...
Mouse monoclonal [CRC64] to Integrin alpha 2b + beta 3 ( Abpromise for all tested applications). Antigen: Human platelets Entrez Gene ID: 23295 Swiss Protein ID: P05106...
This antibody detects cdc42 on SDS-PAGE immunoblots....
Goat anti-PITPN Class: Antibody Product Group: Miscellaneous Antibody...
Biology Products: